AEON Biopharma, Inc.
AEON
Rank in Stocks
#29146
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Share Price
$0.1714
Last synced: 2026-11-11
Market Cap
$8.66M
Change (1 day)
-4.41%
Change (1 year)
-81.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AEON Biopharma, Inc. (AEON)
Category
Healthcare
EPS for AEON Biopharma, Inc. (AEON)
EPS as of June 2026 TTM: $-3.77
According to AEON Biopharma, Inc.'s latest financial reports, its current EPS (TTM) is $-3.77. At the end of 2025 the company had an EPS of $-3.95, a decrease compared to its 2024 EPS of $77.74.
EPS history for AEON Biopharma, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.77 | -4.56% |
| 2025 | $-3.95 | -105.08% |
| 2024 | $77.74 | -110.44% |
| 2023 | $-744.83 | 2,633.32% |
| 2022 | $-27.25 | -244.49% |
| 2021 | $18.86 | -262,044.44% |
| 2020 | $-0.01 | -100.00% |
| 2019 | $1.48K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -515.38% |
US
|
|
| $-7.07 | 87.53% |
US
|
|
| $-5.29 | 40.32% |
AU
|
|
| $12.88 | -441.65% |
BE
|
|
| $21.56 | -671.88% |
NL
|
Questions about AEON Biopharma, Inc.'s earnings per share (EPS)
What is AEON Biopharma, Inc.'s earnings per share (EPS)?
AEON Biopharma, Inc.'s earnings per share (EPS) over the last twelve months is $-3.77, as of Jun 2026.
What was AEON Biopharma, Inc.'s earnings per share (EPS) in 2025?
In 2025, AEON Biopharma, Inc.'s earnings per share (EPS) was $-3.95, compared with $77.74 in 2024.
How has AEON Biopharma, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, AEON Biopharma, Inc.'s earnings per share (EPS) was highest in 2024 ($77.74) and lowest in 2023 ($-744.83).
How does AEON Biopharma, Inc.'s earnings per share (EPS) compare with similar companies?
AEON Biopharma, Inc.'s earnings per share (EPS) ($-3.77) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.